The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Chronic Osteomyelitis

Persistent or recurrent bone infection lasting more than 6 weeks characterized by necrotic bone (sequestrum), new bone formation around dead bone (involucrum), and chronic inflammatory response with sinus tract formation; classified by etiology (hematogenous most common in children, contiguous spread from adjacent infected tissue most common in adults from open fractures, surgical procedures, diabetic foot ulcers, pressure sores), pathologic mechanism (Cierny-Mader anatomic classification — medullary, superficial, localized, diffuse based on extent of bone involvement; physiologic class — A normal host, B with systemic or local compromise), and microbiology (Staphylococcus aureus most common 30-60 percent of cases including MRSA, Pseudomonas aeruginosa with diabetic foot, mixed flora with diabetic foot and pressure sores, Mycobacterium tuberculosis in endemic regions, fungal infections in immunocompromised); diagnosis combines clinical assessment (chronic draining sinus, persistent pain, soft tissue changes), imaging (MRI most sensitive, plain radiography for late changes, CT for sequestrum, nuclear medicine for activity), laboratory (ESR, CRP, complete blood count, blood cultures), bone biopsy with histopathology and culture (gold standard for definitive diagnosis); treatment requires combination of surgical debridement (essential for cure with removal of all necrotic bone, drainage of sinuses, fragment removal), prolonged antibiotic therapy (typically 4-6 weeks IV followed by oral, total duration depending on extent and host factors), and management of underlying conditions (diabetes optimization, vascular reconstruction, pressure ulcer healing); cure rate 70-80 percent with appropriate combined treatment, recurrence common, treatment may require multiple debridements and reconstruction including bone grafting, soft tissue coverage, occasionally amputation for refractory cases.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Ortopedi ve Travmatoloji department. Book Appointment →

What is Chronic Osteomyelitis?

Chronic osteomyelitis is persistent or recurrent bone infection that lasts longer than 6 weeks, distinguished from acute osteomyelitis by the presence of necrotic bone (sequestrum), reactive new bone formation around dead bone (involucrum), chronic inflammatory tissue, and frequent sinus tract formation. Chronic osteomyelitis represents one of the most challenging conditions in orthopedic infection management, requiring complex multidisciplinary treatment including surgical debridement, prolonged antibiotic therapy, and management of underlying conditions and host factors.

Pathophysiology and characteristics: 1) Persistent infection — bacteria harbored in necrotic bone (sequestrum) and biofilms providing protected sanctuary from immune system and antibiotics; 2) Necrotic bone (sequestrum) — devitalized bone fragments that lose blood supply and harbor bacteria; can be small or extensive; 3) Reactive new bone (involucrum) — new periosteal bone formation around devitalized sequestrum, creates characteristic radiographic appearance; 4) Sinus tract — chronic draining tract from infected bone to skin surface; presence indicates communication with infected bone; can be source of new infection; 5) Biofilm formation — bacteria within biofilms have decreased susceptibility to antibiotics and immune mechanisms (10-1000 fold less susceptible); biofilm formation common with S. aureus, S. epidermidis, P. aeruginosa; 6) Chronic inflammation — ongoing inflammatory response with possible amyloidosis after long-standing infection; 7) Compromised local environment — fibrosis, scar tissue, decreased blood supply, decreased antibiotic penetration; 8) Pathologic fracture risk — weakened bone from extensive necrosis; 9) Amyloidosis — rare but recognized complication of long-standing chronic infection (5+ years); systemic AA amyloidosis affecting kidneys, heart, GI tract.

Etiologies and risk factors: 1) Acute hematogenous spread progressing to chronic — failed acute treatment, undiagnosed, undertreatment; 2) Open fracture — most common cause of chronic osteomyelitis after trauma in adults; high-energy injuries, severe contamination, inadequate initial debridement, prolonged time to surgery; 3) Surgical site infection following orthopedic surgery — especially with implanted hardware, prolonged operative time, immunocompromised patients; 4) Diabetic foot infection — extensive soft tissue ulceration extending to underlying bone, particularly in long-standing diabetics with peripheral neuropathy and vascular insufficiency; 5) Pressure sore (decubitus ulcer) extending to bone — sacral, ischial, heel locations particularly; 6) Vertebral osteomyelitis — typically hematogenous spread from urinary tract, IV drug use, post-procedural; 7) Post-puncture wound foot infection — Pseudomonas particularly common (especially with rubber sole footwear); 8) IV drug use — hematogenous spread to spine particularly; 9) Sickle cell disease — Salmonella osteomyelitis classic, also S. aureus; 10) Post-radiation osteonecrosis with secondary infection; 11) Periodontal disease — extension to mandible (osteomyelitis of jaw); 12) Specific predisposing conditions — diabetes mellitus, peripheral vascular disease, immunosuppression, alcoholism, malnutrition, chronic kidney disease, IV drug use, sickle cell disease, HIV.

Microbiology: 1) Staphylococcus aureus — most common pathogen overall (30-60 percent of cases); MRSA increasingly common (community-acquired and hospital-acquired); particularly common in hematogenous and post-traumatic infections; biofilm-producing strains pose treatment challenges; 2) Coagulase-negative Staphylococci (S. epidermidis) — particularly with implanted hardware (orthopedic implants, prosthetic joints), biofilm formation typical; 3) Pseudomonas aeruginosa — diabetic foot infection, water exposure, post-puncture wound through rubber sole, immunocompromised patients; 4) Streptococcus species — Group A streptococcus (S. pyogenes), Group B streptococcus (more in adults); 5) Enterobacteriaceae (E. coli, Klebsiella, Proteus) — diabetic foot, pressure sores, hematogenous from urinary tract; 6) Anaerobes — Bacteroides fragilis, Peptostreptococcus, Clostridium; common in diabetic foot, pressure sores, post-traumatic; 7) Mixed polymicrobial — particularly diabetic foot ulcers, pressure sores, post-traumatic infections; often 3-5 different organisms; 8) Mycobacterium tuberculosis — Pott disease (spinal tuberculosis), peripheral skeletal tuberculosis; particularly important in endemic regions, immunocompromised patients (HIV); 9) Atypical mycobacteria (M. fortuitum, M. marinum) — water exposure, immunocompromised; 10) Fungal — Candida in immunocompromised, IV drug users; dimorphic fungi (Coccidioides, Blastomyces, Histoplasma) in endemic regions; 11) Brucella — endemic regions, contact with cattle and dairy products.

Symptoms

Chronic draining sinus tract (foul-smelling discharge, persistent for weeks/months/years)
Persistent localized pain over affected bone
Persistent or intermittent low-grade fever (uncommon in chronic, more in acute)
Erythema and warmth over affected area
Soft tissue swelling around infected bone
Visible bone or bone fragments at sinus opening
Foul odor from drainage
Decreased range of motion of adjacent joints
Pathologic fracture from weakened bone
Visible bone deformity
Chronic skin changes (chronic dermatitis, lichenification, hypopigmentation around sinus)
Recurring episodes of acute infection
Chronic pain affecting daily activities and sleep
Difficulty walking or weight-bearing
Anemia of chronic disease
Weight loss with chronic infection
Fatigue and malaise
History of trauma, surgery, or chronic ulcer
Diabetes with foot ulcer extending to bone
Prior orthopedic surgery with persistent infection
Recurrent abscess formation
Soft tissue contracture around chronic wound
Functional impairment and limited mobility
Amyloidosis features (proteinuria, edema, GI symptoms in long-standing infection)

Risk Factors

Open fracture (especially Gustilo III)
Surgical site infection following orthopedic surgery
Inadequate debridement of acute infection
Diabetes mellitus with peripheral neuropathy
Diabetic foot ulcer
Peripheral vascular disease
Pressure sore (decubitus)
Sacral, ischial, heel pressure sores
Post-radiation osteonecrosis
Post-puncture wound through shoe
IV drug use (hematogenous spread)
Sickle cell disease
Immunosuppression (HIV, transplant, chemotherapy)
Malnutrition
Chronic kidney disease
Smoking (impaired bone healing)
Alcohol abuse
Spinal cord injury (pressure sores)
Bedridden status
Severe peripheral arterial disease
Rheumatoid arthritis on biologics
Periodontal disease (extension to mandible)
Tuberculosis exposure (Pott disease)
Failed previous treatment
Implanted orthopedic hardware (prosthetic joint, plates, rods)
Prior osteomyelitis treated incompletely
Persistent draining wound for > 6 weeks

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Persistent draining wound or sinus over bone (> 6 weeks)
  • Chronic localized bone pain
  • Recurrent infection at same site
  • Diabetic foot ulcer not healing
  • Pressure sore exposing bone
  • Failed treatment of acute osteomyelitis
  • New onset of fever in patient with chronic wound
  • Suspected pathologic fracture
  • Worsening chronic wound
  • Foul-smelling drainage from chronic wound
  • Visible bone or bone fragments at wound site
  • Spinal pain with possible vertebral osteomyelitis
  • Post-orthopedic surgical wound problems
  • Prosthetic joint pain or drainage
  • Suspected spinal tuberculosis (Pott disease)
  • Compromised soft tissue over chronic wound
  • Chronic wound with associated lymphadenopathy
  • Worsening function or mobility
  • Pre-operative planning for chronic osteomyelitis surgery
  • Recurrence after treatment
  • Suspected amyloidosis (long-standing chronic infection)
  • Symptoms of systemic infection in chronic osteomyelitis
  • Pre-amputation evaluation

Treatment Methods

01
Initial assessment: 1) Comprehensive history including duration, prior treatments, comorbidities (especially diabetes, vascular disease, immunocompromise), trauma or surgery history, IV drug use, tuberculosis exposure, travel history, current medications, allergies; 2) Detailed physical examination — wound assessment (size, depth, drainage, tunneling, surrounding tissue), bone exposure or palpable bone, sinus tract probe (probing to bone test — positive predictive value 90 percent for osteomyelitis in diabetic foot), neurovascular examination, range of motion of adjacent joints, vascular examination including pulses; 3) Wound depth assessment using sterile probe; 4) Photographic documentation; 5) Pain assessment; 6) Functional assessment
02
Diagnostic workup: 1) Complete blood count (anemia of chronic disease, leukocytosis less prominent in chronic), ESR (often elevated 30-100 mm/hr, normalization with treatment but slow), CRP (more sensitive for monitoring response), comprehensive metabolic panel; 2) Blood cultures (positive in 50-70 percent of acute episodes, less reliable in chronic); 3) Wound and sinus tract cultures — superficial cultures unreliable due to colonization, deep cultures with debridement and bone biopsy more reliable; 4) Bone biopsy with histopathology and culture — gold standard for definitive diagnosis; obtained surgically or via image guidance; histopathology shows necrotic bone, inflammatory cells, granulation tissue, fibrosis, possibly malignancy in long-standing infection; cultures with sensitivities essential for targeted antibiotic therapy; 5) Plain radiography — late changes including sequestrum, periosteal reaction, lytic lesions, sclerosis, new bone formation, cortical destruction; sensitivity low early in disease; 6) MRI — most sensitive imaging (90+ percent), identifies marrow edema and abscess, soft tissue extent, sinus tract, sequestrum (preferred for assessment); 7) CT — excellent for sequestrum identification (better than MRI for cortical bone), surgical planning, image-guided biopsy; 8) Nuclear medicine — bone scan (technetium) sensitive but not specific; gallium scan and indium-labeled WBC scan more specific; FDG-PET emerging; 9) Specific tests when indicated — quantitative interferon-gamma release assays for TB, HIV testing, vasculitis workup if vascular insufficiency suspected; 10) Vascular studies (ABI, Doppler, angiography) for vascular insufficiency and surgical planning; 11) Endocrinology evaluation in diabetic patients; 12) Multidisciplinary tumor board for differential of malignancy versus chronic infection in some cases
03
Surgical debridement: 1) Cornerstone of cure for chronic osteomyelitis; antibiotics alone insufficient due to necrotic bone harboring infection; 2) Surgical principles include: a) Removal of all necrotic bone (sequestrum) — bone fragments dead and harbor bacteria; b) Debridement to bleeding bone — removal of all infected/necrotic tissue and devitalized bone until well-vascularized normal-appearing bone; c) Drainage of abscesses; d) Removal of foreign material (hardware if any); e) Soft tissue debridement; f) Multiple debridements often needed (every 48-72 hours initially); g) Negative pressure wound therapy (VAC) for ongoing soft tissue management; 3) Specific approaches based on Cierny-Mader stage: Stage 1 (medullary) — drilling and irrigation, intramedullary curettage; Stage 2 (superficial) — surface debridement, bone resurfacing; Stage 3 (localized) — focal cortical debridement preserving stability; Stage 4 (diffuse) — extensive debridement requiring stabilization, possible reconstruction including muscle transposition flap, bone grafting, free vascularized tissue transfer; 4) Salvage strategies — Ilizarov bone transport for segmental defects, vascularized fibula transfer, autologous cancellous bone grafting, bone morphogenetic proteins (rhBMP-2 in trials); 5) Pathologic fracture management — internal or external fixation, possible bone transport for healing; 6) Amputation — for refractory infection, severe vascular compromise, severe deformity, multidrug-resistant infection in immunocompromised patient
04
Antibiotic therapy: 1) Initial empirical therapy based on suspected pathogens (host factors, local epidemiology, MRSA prevalence) — vancomycin for MRSA coverage plus broad-spectrum gram-negative coverage (cefepime, piperacillin-tazobactam, ceftriaxone) until culture sensitivities; 2) Targeted therapy after culture sensitivities; 3) Duration of therapy: a) Cure with combined surgical and antibiotic treatment requires extended therapy; b) Typically 4-6 weeks IV antibiotics for chronic osteomyelitis; c) Followed by oral antibiotics for 2-6 weeks (total typical 6-12 weeks); d) Some advocate longer therapy (6 months in tuberculosis, fungal infections, with biofilm formation); e) Suppressive antibiotic therapy in some cases (chronic suppressive antibiotics for life when cure not possible); 4) Specific organism considerations: a) MRSA — vancomycin (target trough 15-20 mcg/mL), daptomycin alternative, linezolid alternative, ceftaroline emerging; b) Methicillin-sensitive S. aureus — nafcillin, cefazolin, oxacillin (preferred over vancomycin); c) Pseudomonas — anti-pseudomonal beta-lactam (cefepime, piperacillin-tazobactam, ceftazidime, meropenem) plus aminoglycoside or fluoroquinolone; d) Streptococcus — penicillin G, ceftriaxone; e) Enterobacteriaceae — third generation cephalosporin, fluoroquinolone, beta-lactam-beta-lactamase inhibitor; f) Anaerobes — metronidazole, clindamycin, beta-lactam-beta-lactamase inhibitor; g) Tuberculosis — rifampin, isoniazid, pyrazinamide, ethambutol for 6-12 months; h) Fungal — fluconazole, voriconazole, amphotericin B based on organism; 5) Combination therapy with rifampin (for biofilm-producing organisms — S. aureus, coagulase-negative staphylococci); 6) Outpatient parenteral antibiotic therapy (OPAT) — for completion of IV therapy at home with central venous access (PICC), regular monitoring of drug levels and clinical status; 7) Oral antibiotics with good bone penetration — fluoroquinolones (ciprofloxacin, levofloxacin), trimethoprim-sulfamethoxazole, linezolid, clindamycin
05
Wound care and adjunct therapies: 1) Negative pressure wound therapy (VAC) — promotes granulation tissue, bacterial reduction, fluid removal, edema control; standard adjunct in modern wound care; 2) Hyperbaric oxygen therapy (HBOT) — controversial benefit, some evidence for refractory osteomyelitis especially with vascular compromise, post-radiation osteonecrosis, fungal infections; 3) Antibiotic-impregnated cement spacers (PMMA — polymethylmethacrylate) loaded with antibiotics (gentamicin, vancomycin, tobramycin) for local delivery; 4) Antibiotic-impregnated calcium phosphate or bioactive glass beads for local delivery with bone substitute properties; 5) Maggot therapy (medical maggots) — selective debridement of necrotic tissue; 6) Standard wound care including debridement, moisture balance, infection control, edge effect (TIME principle); 7) Compression therapy for venous insufficiency; 8) Off-loading for diabetic foot (total contact casting, removable cast walker); 9) Nutritional optimization; 10) Tobacco cessation counseling
06
Reconstructive surgery: 1) Indications include large defects after debridement, segmental bone loss, soft tissue coverage requirements, joint reconstruction, deformity correction; 2) Bone reconstruction options: a) Autologous bone graft (cancellous, vascularized, including vascularized fibular graft); b) Allograft bone; c) Bone substitutes (calcium sulfate, calcium phosphate, demineralized bone matrix); d) Bone morphogenetic proteins (BMP); e) Distraction osteogenesis (Ilizarov bone transport, hexapod fixator) for segmental defects; 3) Soft tissue coverage: a) Local advancement flaps; b) Regional flaps (gastrocnemius for proximal tibia, soleus for middle tibia, sural artery flap, peroneus longus); c) Free vascularized tissue transfer (latissimus dorsi, anterolateral thigh, gracilis, rectus abdominis); d) Skin grafting; 4) Combined bone and soft tissue reconstruction — emphasis on staged reconstruction with adequate debridement and soft tissue coverage before definitive bone reconstruction; 5) External fixation provides stabilization during reconstruction; 6) Limb salvage versus amputation discussion based on functional outcomes, comorbidities, infection control, quality of life
07
Treatment of underlying conditions: 1) Diabetes mellitus — strict glycemic control (HbA1c < 7 percent goal), nutritional optimization, vascular evaluation; 2) Peripheral vascular disease — vascular reconstruction (open or endovascular) when feasible to improve perfusion; 3) Pressure ulcer — pressure relief (specialty mattress, regular position changes, off-loading), nutritional support; 4) Tobacco cessation — significantly improves bone healing and infection cure rates; 5) Nutritional optimization — protein supplementation, vitamins (C, D), minerals (zinc, copper); 6) HIV management — antiretroviral therapy, opportunistic infection prevention; 7) Treatment of malignancy if related; 8) Mobilization and physical therapy; 9) Psychiatric support for chronic pain and depression
08
Multidisciplinary management and follow-up: 1) Team includes orthopedic surgery (sometimes infectious disease orthopedic specialist), infectious disease, plastic surgery (for soft tissue coverage), vascular surgery, endocrinology (diabetes), wound care nursing, physical therapy, psychiatry/social work, pain management; 2) Coordinated care plan with regular multidisciplinary discussions; 3) Follow-up frequency typically every 1-2 weeks during active treatment, then less frequent; 4) Long-term follow-up for at least 1-2 years to detect recurrence; 5) Imaging follow-up (MRI, plain radiographs) at intervals; 6) Laboratory monitoring (ESR, CRP); 7) Clinical assessment of wound, function, pain; 8) Patient education throughout treatment; 9) Quality of life and functional outcome assessment; 10) Long-term complications surveillance (amyloidosis, malignant transformation — Marjolin ulcer in chronic osteomyelitis with sinus tract)
09
Long-term outcomes and prognosis: 1) Cure rate 70-80 percent with appropriate combined treatment; 2) Recurrence common (10-30 percent) requiring repeat treatment; 3) Functional outcomes vary widely based on extent of bone and soft tissue loss, comorbidities, age, host factors; 4) Quality of life impact significant — chronic pain, mobility limitation, financial burden, psychological impact; 5) Marjolin ulcer (squamous cell carcinoma in chronic ulcer) — recognized complication of long-standing chronic osteomyelitis sinus tract (10-30 years); requires biopsy of any non-healing or growing area; 6) Amyloidosis — rare but serious complication with renal, cardiac involvement; 7) Amputation may be necessary in 5-10 percent of refractory cases or with extensive disease; 8) Patient must be counseled about expected prolonged treatment course (months to years), need for multiple procedures, possibility of recurrence; 9) Adherence to long-term antibiotic therapy and wound care critical for success; 10) Continued research into novel therapies including new antibiotics, anti-biofilm agents, immunomodulators, regenerative medicine approaches

Which Department to Visit?

You can visit our Ortopedi ve Travmatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Ortopedi ve Travmatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Low Back Pain and Lumbar Disc Herniation

Ortopedi ve Travmatoloji

Lumbar disc herniation occurs when the outer layer of the disc between the vertebrae tears and the inner part presses on nerve tissue, causing low back and leg pain.

Cervical Disc Herniation

Ortopedi ve Travmatoloji

Cervical disc herniation is a condition in which the disc between the vertebrae in the neck region presses on a nerve root or the spinal cord, causing neck, shoulder, and arm pain.

Knee Pain and Meniscus Tear

Ortopedi ve Travmatoloji

Meniscus tear is a tearing of the cartilage structures in the knee joint as a result of a sudden twisting movement or degeneration and is one of the most common causes of knee pain.

Shoulder Pain and Frozen Shoulder

Ortopedi ve Travmatoloji

Frozen shoulder (adhesive capsulitis) is a chronic condition characterized by inflammation and thickening of the shoulder joint capsule, causing restriction of movement in all directions and severe pain.

Bone Fractures

Ortopedi ve Travmatoloji

A fracture is partial or complete disruption of the integrity of bone tissue due to an external force or bone disease, and it can occur at any age.

Wrist Fracture (Distal Radius Fracture)

Ortopedi ve Travmatoloji

Distal radius fracture is one of the most common reasons for emergency room visits; it occurs when the radius bone fractures at the wrist end due to the hand being planted on the ground during a fall.

Hip Fracture

Ortopedi ve Travmatoloji

Hip fracture is a serious fracture mostly occurring in elderly individuals with osteoporosis due to a fall in the femoral neck or trochanteric region, and early surgical treatment is life-saving.

Ankle Sprain

Ortopedi ve Travmatoloji

Ankle sprain is a partial or complete tear of the ankle ligaments, most commonly involving the lateral ligament complex (ATFL, CFL, PTFL) after an inversion injury.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.